Optimizing Dosing Regimen of Piperacillin/Tazobactam for Nosocomial Pneumonia

Update Il y a 5 ans
Reference: NCT01796717

Woman and Man

  • | Country :
  • China
  • | organs :
  • -
  • | Specialty :
  • -

Extract

1. To observe clinical and bacteriologic responses of different regimens of piperacillin/tazobactam (4.5g q6h, prolonged or intermittent infusion) for treatment of nosocomial pneumonia. 2. To describe the pharmacokinetic profile of piperacillin/tazobactam (4.5g q6h, prolonged or intermittent infusion) in patients with nosocomial pneumonia. 3. To assess the safety profiles of piperacillin/tazobactam 4.5g q6h, prolonged or intermittent infusion in patients with nosocomial pneumonia.


Inclusion criteria

  • Nosocomial Pneumonia

Links